India’s First Indigenous African Swine Fever Vaccine

|

India’s First Indigenous African Swine Fever Vaccine

Science & Technology
India’s First Indigenous African Swine Fever Vaccine

Scientists at ICAR-National Institute of High Security Animal Diseases (ICAR-NIHSAD) develop India’s first indigenous African Swine Fever (ASF) vaccine. The vaccine is reported as a live attenuated, MA-104 cell line-based vaccine, in the context of ASF affecting domestic and wild pigs.

Indigenous African Swine Fever (ASF) Vaccine:

Dimension Key Details
Developing institution The vaccine is developed by ICAR-National Institute of High Security Animal Diseases (ICAR-NIHSAD).
Vaccine type and platform The vaccine comprises a live attenuated, MA-104 cell line-based vaccine.
Significance The vaccine authorises enhanced disease preparedness, protection of pig farmers' livelihoods, support to the swine industry, and strengthening of India's veterinary biotechnology capabilities.
ASF nature ASF comprises a highly contagious viral disease.
Causative agent African Swine Fever Virus (ASFV) comprises the causative agent of ASF.
Species affected To domestic and wild pigs only.
Mortality To mortality that may reach 100%.
Human health risk No risk to human health.
Economic impact Severe economic losses.
Transmission routes ASF transmission comprises infected pigs, contaminated pork products, fomites, and soft ticks.
Did you find this informative?

Attempt Possible Qs

Q 1 / 2

With reference to the indigenous ASF vaccine, consider the following statements:

1. It is developed by ICAR-NIHSAD.
2. It is a MA-104 cell line-based vaccine.
3. It is described as a live attenuated vaccine.

Which of the statements given above are correct?